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Walmsley et al Flexible dialyser membrane.
dialyser membrane would continuously flex as samples of
different protein concentrations are analysed the peak
height of a specimen does not necessarily reflect its
creatinine level. In the authors’ experience this produces
many bizarre peak shapes within every batch and the last
peak is always higher than expected. One way of minimising
conformational changes in the dialyser membrane is to raise
the waste donor stream Of the dialyser. However, under these
conditions small changes in conformation still occur due to
the elasticity in the membrane, and the last peak in every
batch is still higher than expected. A-satisfactory solution to
this problem has been found by minimising pressure
differences between samples. A plasma creatinine analyser
has been operated for the last 18 months using a sample
diluent of sodium chloride (300 mmol/1) and 10 g/1 of Brij
35. Over 75,000 specimens were analysed during this time. A
higher concentration of 30 g/1 is not used, in order to reduce
the possibility of phase separation when samples of high total
protein are analysed ].
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Introduction
Fully enzymatic methods for the determination of serum
triglycerides may be carried out in either .a kinetic or an
equilibrium mode. Both kinetic and equilibrium methods
have been adapted for use on centrifugal analysers.Kinetic(or
fixed-time rate) analyses are carried out by adapting the
reaction conditions to achieve first or pseudo-first-order
kinetics 1-5]. Equilibrium analyses on centrifgual analysers
deal with some special problems concerning the initial
absorbance reading [1,6]. If a slight lag-phase is present in
the first stage of the reaction some analysers can read an
initial absorbance during this time. Otherwise ’zero-time’.
extrapolation procedures must be used despite the difficulties
these present. Another drawback of equilibrium analyses,
especially for centrifugal analysers, is the long reaction time.
A fully enzymatic equilibrium method adapted to the
Gemsaec Fast analyser which takes less than two minutes of
instrument time is described. It is a modification of the
method described by Bucolo.et al [7]. in this procedure the
triglycerides are released and hydrolysed by a mixture of
lipase and 0t-chymotrypsin. Subsequently, the released
glycerol is converted to glycerol-l-phosphate in the presence
of glycerol kinase and ATP. Phosphoenol pyruvate, included
in the reagent, is converted by pyruvatekinase to pyruvate
resulting in the regeneration ATP from ADP. The reduction
of pyruvate to lactate in the presence of lactate dehydro-
genase with concurrent oxidation of NADH2 to NAD+ is
used as the indicator reaction. Both the hydrolysis and the
elimination of glycerol are carried out at 37 C in the transfer
disc outside the analyser within 10 minutes.
To minimise optical interferences, the absorbance of the
reaction mixture is read after 10 minutes at two wavelengths,
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namely 340 nm and 380 nm. There is no optical interference
by lipemic sera as the absorbances are determined after com-
plete hydrolysis of the lipids. The concentration of
triglycerides is calculated by subtracting the absorbance
differences (A 340 nm A 380 nm) of the reagent blank and
determinations compared to that of a glycerol standard.
Materials
Eskalab triglyceride reagent
Eskalab substrate vials (89804) and Eskalab glycerol kinase
vials (89802), obtained from Smith Kline Instruments, Inc.,
Sunnyvale, California 94086, USA, were dissolved in hi-
distilled water according to the manufacturer’s recommend-
ations. The reactants in the reagent mixture have the
following approximate concentrations:
Substrate mixture
Reduced nicotinamide adenine dinucleotide
Pyruvate kinase
Lactate dehydrogenase
MgZ+
Lipase
ot-chymotrypsin
Phosphoenol pyruvate
Bovine serum albumin
Adenosine triphosphate
Buffer: (pH 7.1 : 0.2)
Potassium dihydrogen phosphate
di-Potassium hydrogen phosphate
0.3 mmol/1
0.8 x 103IU
0.7 x 103IU
6 mmol/1
300 x 103 IU
13 x 103IU
0.8 mmol/1
1.7 g/1
0.5 retool/1
10 mmol/1
63 mmol/1
Glycerol kinase suspension
Glycerol kinase not less than 20 IU/vial.
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Combined reagent
10pl Of the glycerol kinase suspension were added per ml of
the substrate solution and the reagent was mixed.
Glycerol standards
100% Glycerol, purchased from Fluka A. G., Buchs S. G.
(Prod. no 49770) was used as the primary standard. The
water content of the 100% glycerol was checked by
measuring the relative viscosity at 20.0C [8]. As a
secondary standard Precimat glycerol standard, obtained
from Boehringer Mannheim GmbH, Germany, was used.
This is a stabilised aqueous solution of glycerol which
contains 2.29 mmol/1 glycerol, corresponding to a trigly-
ceride concentration of 2.29 mmol/1. This standard was
checked with aqueous dilutions (v/v) of 100% glycerol.
Ethanolic potassium hydroxide (ca. 0.5 mol/1)
3.30 g 85% Potassium hydroxide p.a. (Merck art. 5033) were
dissolved in 10 ml bidistilled water, under cooling with tap
water. 96% Ethanol p.a. (Merck art. 972) was added to a
final volume of 100 ml.
Magnesium sulphate solution (0.15 mol/1)
3.70 g Magnesium sulphate 7 aq. p.a. (Merck art. 5886)
were dissolved in 50 ml bidistilled water and bidistilled
water was added to a final volume of 100 ml.
Boehringer test-combination triglycerides
All reagents in this kit (no. 124966), purchased from
Boehringer Mannheim GmbH, Germany, were dissolved
in bidistilled water according to the manufacturer’s
recommendations.
Turbidity standard
5 g Hexamethylene tetramine (Merck art. 4343) were dis-
solved in 30 ml bidistilled water and brought to a final
volume of 50 ml. 0.5 g Hydrazine sulphate (BDH ’analar’
no. 10121) were dissolved in the same way to a final volume
of 50 ml. Both solutions were combined (1:1) to a stock-
standard. The working-standard was prepared by dilution of
12 ml stock-standard with bidistilled water to a volume of
50 ml.
Apparatus
1. ENI-Gemsaec centrifugal analyser obtained from Electro-
Nucleonics Inc., Fairfield, New Jersey 07006, USA, with
optional addition of a Digital Decwriter II and an ENI-
Gemsaec rotoloader IV with Micromedic Systems auto-
matic pipettes.
2. LKB ultrolab system 2074 calculating absorptiometer
obtained from LKB Produkter AB, Bromma 1, Sweden.
3. A Vitatron Photometer UFD, was used as a nephelometer
without optical filters, obtained from Vitatron, Dieren,
The Netherlands.
Methods
The transfer discs are prewarmed to the incubation temper-
ature (37C) before they are loaded. 10/al Bidistilled water,
standard, control or serum sample, dispensed with 80
saline followed by 500 /al combined reagent (see Materials)
are pipetted into well C of the transfer disc. Positions 1,
2 and 3 of the transfer disc contain bidistilled water, reagent
blank and a glycerol standard respectively.
After an incubation at 37C for 10 minutes the hydroly-
sis of the triglycerides and elimination of glycerol has been
completed and the transfer disc is placed into the Gemsaec
analyser and the run is started. The analyser is operated at
37C and the first reading at 340 nm is taken after 10
seconds (IR 10). Thirty seconds after the vacuum blast
(mixing) the wavelength is-changed to 380 nm and the
second reading is taken 60 seconds after the first reading
(RI 60, NR 2).
The computer instructions are as follows
IR 10 AD 3
RI 60 CD 2
NR 2 HI 2.5
SC 2.29 LO 0.5
KT 1.0 SA 0.4
TF 1.0 RM 2
TC XX
To calculate correctly the total glycerol concentration of
the samples, the first printout must be disregarded and an
additional computer program must be used (see Manual SKI).
This program performs the following calculations using the
absorbances stored in the computer memory"
1. A340 Aas0 Delta in which A340 absorbance at
340nm
Aa 80 : absorbance at
380nm
2. Deltablank Deltasamples A corrected
3. A corrected unknown x glycerol concentration of standard
A corrected standard (mmoi[1)
total glycerol concentration of
unknown (mmol/1)
Results were compared to the manual enzymatic method
after saponification with ethanolic KOH (see Materials)
which was performed according to the manufacturers recom-
mendations. In routine clinical chemistry, the triglyceride
concentration is obtained by subtracting 0.11 mmol/1 as
correction for the mean free glycerol concentration,, from the
measured value [9]. Otherwise the concentration of ’free’
glycerol may be estimated, separately.
Experiments and results
Wavelength choice
The glycerol concentration of an aqueous glycerol solution
is generally measured by determining the absorbance
difference between the reagent blank and the sample relative
to the absorbance difference between the reagent blank and a
standard at one wavelength (340 nm). When optical ’normal’
sera diluted in the combined reagent as described earlier are
analysed in this way, the triglyceride concentrationwill be
decreased by approximately 0.1 0.2 mmol/1.
As it is impossible to read the initial absorbance of the
reaction mixture at the Gemsaec Fast analyser, an altern-
ative approach is to measure the absorbance of the reaction
mixture at two wavelengths, after completion of hydrolysis
and elimination of glycerol. The choice of the second wave-
length, next to the fixed 340 nm, is based on several factors.
Firstly, interference caused by haemolytic and ictedc
samples must be minimised. Secondly, the sensitivity of the
assay must be guaranteed and thirdly, the practical.handling
of the assay on the Gemsaec analyser is of importance.
To evaluate the possible colorimetric interferences spectra
were measured of haemolytic and icteric sera in the reaction
mixture without glycerolkinase against the same mixture
without these pigments. These experiments showed that
minimum interference of haemolysis was given if the second
wavelength is about 375 nm. To evaluate the interference
caused by icteric samples spectra of icteric sera with a high
and low percentage conjugated bilirubin were measured. As
the absorption minimum for both spectra is about 340 nm it
appeared that for minimising the interference of bilirubin
the best choice for the second wavelength is about 340 nm.
The sensitivity of the assay is dependent on the
absorbance difference between 340 nm and the second wave-
length. The choice of a high wavelength (>390 nm) will
guarantee good sensitivity (a large absorbance difference)
but, as stated above, will cause erroneous results especially
when assaying icteric samples. The choice of a low wave-
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length (<370 nm) will result in minimal interference caused
by icteric samples but pronounced interference caused by
haemolytic samples and loss of sensitivity. In prac.tice, the
choice of 380 nm as the second wavelength offers a reasonable
compromise. The interference of pigments at this wavelength
is acceptable and the sensitivity is guaranteed as the corrected
absorbance (Delta blank Delta sample) for a triglyceride
concentration of 2.3 mmol/1 (reference range 0.84 1.94) is
36% higher than the corrected absorbance at 370 nm.
Furthermore, changing the wavelength during the assay on
the Gemsaec spectrophotometer from 340 nm to 380 nm
and calibration and checking the cuvettes at both wave-
lengths presents no practical problems as the same filter
range can be used.
The repeated adjustment of the wavelength scale at the
chosen wavelengths is sufficiently exact.
Linearity
A series of glycerol standards was prepared by diluting 100%
glycerol (primary standard) with bidistilled water (v/v).
The primary standards were assayed four times and the
glycerol concentrations were calculated against the secondary
Precimat glycerol standard. The results (Figure 1) show that
there is good linearity over the range of glycerol concen-
trations from 0 up to 7.5 mmol/1 (max. deviation from
calculated glycerol concentration 0.5%). Furthermore, the
results show that the stated glycerol concentration of the
Precimat standard is correct.
Precision
The within-run precision was determined by assaying serum
pools with different triglyceride concentrations in three runs.
In each. run aliquots of the same serum were pipetted in 13
wells of the transfer disc. The’ results are presented in Table
1. The day-to-day precision was determined by assaying the
control serum liponorm (Boehringer Mannheim GmbH) once
a day in duplicate..The results over a period of 32 days are
.also shown in Table 1.
Accuracy
The automated bichromatic enzymatic method was
compared to a manual enzymatic method, the Boehringer
test-combination triglycerides. Seventy-three sera were
analysed by both methods. The results are shown in Figure
2. The correlation curve, calculated according to Lindley
[10] assuming that the variances in x and y are equal, is
described by the eqUation
y 1.03x 0.05
with a coefficient of correlation of 0.996. The data followed
a normal distribution, checked with the Kolmogorov-
Smirnov-test 11 (a 0.05).
Interference of haemoglobin
Any interference of haemolysis with this bichromatic
method was investigated. Blood from a healthy donor was
centrifuged after clotting and the blood clot was washed
twice with 0.9 g/1 NaCI. Erythrocytes were haemolysed by
Table 1. Within-run and day-to-day precision of three sera and one control serum, respectively
Sample
Mean (mmol/1) concentration of triglycerides
Standard deviation (mmol/1)
Coefficient of variation (%)
Number of samples
Number of days
Within-run
A B
0.49 1.81
0.012
2.6
13
0.026
1.4
13
3’19
0.048
1.5
13
Day-to-day
Liponorm
1.93
0.048
2.5
32
Table 2. Influence of haemolysis on the determination of triglyeerides
Haemoglobin
concentration
(mmol/1)
0.00
0.03
0.06
0.12
0.23
Qualitative haemolysis
according to Frank
et al 121
2+
3+
4+
Expected triglyceride
concentration
(mmol/1)
2.16
2.15
2.14
2.12
2.08
Measured triglyceride
concentration
(mmol/1)
2.16
2.18
2.20
2.21
2.23
Apparent increase in
triglyceride concentration
(mmol/1)
0.00
0.03
0.06
0.09
0.15
ca,c lOy told al lo31
Figure 1. Glycerol concentrations measured by the dual
wavelength method on the Gemsaec Fast analyser of a
series of glycerol standards prepared by diluting 100%
glycerol with bidistilled water (V/v).
Figure 2. Comparison ofthe triglyceride concentrations of
73 sera analysed with the dual wavelength method on the
Gemsaec Fast analyser and with a manual enzymatic
method after saponification with ethanolic KOH.
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adding bidistilled water and the suspension was homogen-
ised in a mortar. After centrifuging the suspension five
times for 30 minutes at 4000 rpm the haemoglobin sol-
ution had a haemoglobin concentration of 5.5 mmol/1
and a triglyceride concentration of 0.1 mmol/1. A series
of dilutions with pooled serum was prepared. The expected
triglyceride concentration of the haemolytic sera were
calculated from the triglyceride concentration of the pooled
serum (2.16 mmol/1) and the dilution factors obtained
after the addition of the haemoglobin solutions. The trig-
lyceride concentrations of the different haemolytic serum
samples were determined in duplicate on the Gemsaec
analyser by the bichromatic enzymatic method. The four
haemolytic samples were categorised qualitatively in four
clisses (1+, 2+, 3+ and 4+) according to Frank et al [12].
Table 2 shows the results of these experiments. From these
results it is evident that the presence of haemoglobin in
serum results in an apparent increase of the triglyceride
concentration. The authors consider that the influence of
haemolysis which is acceptable for practical purposes as
the triglyceride concentration of a very haemolytic (4+)
sample (which rarely occurs) with an expected triglyceride
concentration of 2.00 mmol/1 (reference range 0.84
1.94 mmol/1) will be increased by about 8%.
Interference of bilirubin
In order to investigate the interference with the bichromatic
method caused by bilirubin, a series of dilutions with saline
were made of four different icteric sera, with a high percent-
age conjugated bilirubin (mean 73%). The diluted samples
were assayed on the Gemsaec analyser in duplicate with sub-
strate without the addition of glycerol kinase to evaluate
the optical interference. The results are presented in Table 3.
From these results it is evident that the presence of bilirubin
in serum results in an apparent increase of triglyceride con-
centration. For example, the triglyceride concentration of an
icteric serum- with a total bilirubin concentration of
100 pmol/1 (reference range 5-14/amol/1) and an expected
triglyceride concentration of 2.00 mmol/1 (reference range
0.84 1.94 mmol/1) will be increased by about 10% when
assayed with this method. As the spectra at about 340 nm of
sera with high concentrations of unconjugated bilirubin in
the reaction mixture are almost the same as the spectra of
sera with high concentrations of conjugated bilirubin, the
interference of unconjugated bilirubin on the assay is not
quantified.
Interference by turbidity
A series of turbid samples prepared by dilution of a strongly
lipemic serum pool of 10 patients (triglyceride concentration
10.1 mmol/1) with saline was assayed, to evaluate the
capability of the combined reagent to clear up sera with a
high content of chylomicrons. The turbidity of the samples
was measured in duplicate on a nephelometer, that was
adjusted to an arbitrary transmission of 40% with the
turbidity standard. The samples were analysed in duplicate
on a Gemsaec analyser diluted with combined reagent with-
out the addition of glycerol kinase to evaluate the influence
of turbidity on the corrected absorbance. The results are
Table 3. Influence of total bilirubin concentration on the
determination of triglycerides
Total bilirubin
concentration
(ktmol/1)
0
5O
100
150
200
250
A corrected + SD (Delta
blank Delta sample)
0.000 + 0.001
0.007 + 0.001
0.016 + 0.001
0026 + 0.002
0.036 + 0.003
0.047 + 0.005
Apparent increase
in triglyceride
concentration
(mmol/1)
0.00
O.O8
0.19
0.32
0.44
0.57
Table 4. Influence of turbidity on the determination of
triglycerides
Dilution
factor
lipemic
serum pool
undiluted
2x
4x
8x
12x
18x
Nephelo-
merry %
transmission
29.3
29.6
23.2
17.0
12.1
A corrected
(Delta blank
-Delta
sample)
-0.017
-0.007
-0.003
-0.001
0.000
0.000
Apparent
decrease in
triglyceride
concentration
(mmol/1)
0.21
0.08
0.04
0.01
0.00
0.00
shown in Table 4. From the results it is clear that even
strongly lipemic sera are sufficiently cleared by the combined
reagent. For example, the triglyceride concentration of the
2 x diluted pooled serum (strongly lipemic) with an expected
triglyceride concentration of 5.0 mmol/1 was decreased by
about 1.5%. Only extreme milky sera cause falsely lowered
triglyceride concentrations but this will not cause erroneous
results as these sera will have a high triglyceride concentra-
tion and dilution will be necessary to prevent crossing the
upper limit of !inearity (7.5 mmol/1).
Discussion
An enzymatic analysis based on an equilibrium measurement
has the advantage over a kinetic measurement that
temperature or drugs have no influence on the kinetics of
the reaction. In addition, a linear reaction curve is not
necessary. The difficulty in adapting an equilibrium analysis
to the Gemsaec analyser is that it is impossible to take an
early absorbance reading. Chong-Kit et al [6] have solved
this problem and introduced a ’zero-time extrapolation’ by
means of an extrapolation factor. The authors evaluated a
bichromatic reading after completion of the reactions which
replaces the ’zero-time extrapolation’. A bichromatic reading
may introduce errors caused by pigments and/or turbidity.
Data presented here shows that these interferences caused by
haemoglobin and bilirubin are not completely minimised
by this bichromatic reading. However, the influence of
haemolysis only becomes important at haemoglobin concen-
trations that seldom occur in practice and the authors
consider that this method is acceptable for practical purposes.
The interference of bilirubin is the result of the choice of
the second wavelength. There is an almost linear relation
between the bilirubin concentration and the apparent
increase in triglyceride concentration; for every 50 /amol/1
bilirubin the triglyceride concentration of an icteric sample
is increased by 0.1 mmol/1. The interference caused by
lipemic turbidity is excluded as the absorbances are deter-
mined after complete hydrolysis of the lipids.
The disadvantage of a long hydrolysis time (10 minutes)
is limited because the incubation takes place outside the
Gemsaec analyser. During this incubation the preceding
batch is run, calculated and the necessary administration
can be performed. In principle this enzymatic analysis of
serum triglycerides can be performed on every spectro-
photometer with variable wavelength setting and on the
recently introduced bichromatic analysers after hydrolysis
of glycerides. The choice for the Gemsaec analyser is based
on the advantage this system offers (economic reagent use,
good precision, easy calculation of results, clear presentation,
statistical evaluation).
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A clinical appraisal ofthe Greiner G300
clinical chemistry analyser
M.J. Hallworth and S.G. Archer
Department of Clinical Biochemistry, Addenbrooke’s Hospital, Hills Road, Cambridge CB2 2QR.
and J.G. Lines
Department of Clinical Chemistry, William Harvey Ho’spital, Ashford, Kent TN24 OLZ.
Introduction
The demands on clinical chemistry laboratories over the last
two decades have grown so rapidly that automated multiple
analysis upon single samples is now the only practicable
method of providing a routine clinical chemistry service in
all but the smallest hospitals. A large variety of equipment is
commercially available for performing this task rapidly and
economically,whilst maintaining high standards of analytical
quality. Any new instrument must therefore equal or better
the established standards of precision, and must use analytical
methods producing results as close as possible to reference
methods for each analyte.
Thework which follows sets out to determine the precision
and accuracy of the Greiner G300 analyser in routine use
and to examine both the analytical capability of the instru-
ment and also the contribution it can make towards handling
the workload of the clinical chemistry laboratory.
The Greiner G300 analyser is a third-generation instrument,
which essentially comprises up-dated modifications of the
Greiner Selective Analyser (GSA II) which has been available
for six years. In the United Kingdom, the GSA II was first
formally evaluated by Skinner and Wilding [I] in 1975, and
a more comprehensive evaluation has recently been produced
by Carlyle et al [2] who made their study over a considerable
period of routine use.
The present evaluation was planned as a rapid assessment
of the clinical utility of the new.G300. Following exhibition
at the 3rd European Congress of Clinical Chemistry (Brighton,
June 1979), a prototype instrument was transported to
Cambridge and was operational for this clinical trial the day
after arrival. Over the next five days a series of experiments
designed to rapidly assess the per-formance of the G300
under routine conditions was performed.
Instrument description
The instrument is a discrete analytical system capable of
performing up to 30 different analyses on a single specimen.
Methods for 20 analyses are already fully documented, and
the repertoire is being extended by further tests as they are
adapted to the G300 from the GSA II.
The G300 is physically smaller than the GSA II and has
improved process control facilities. The number of analyses
on each specimen and the rate of analysis remain the same,
but the handling of emergency and paediatric samples is
faster and more convenient than on the GSA II. A washing
cycle for process tubes is a new feature of the G300 and
contrasts advantageously to the disposable process tubes
used by the GSA II. Carlyle et al [2] found that the cost of
process tubes considerably exceeded the cost of reagents
for most tests, therefore .the economic saving is appreciable.
The G300 comprises a 30 place sample carrier and sampling
unit, a conveyor belt system on which the process tubes
used for reactions are supported and moved, and a ighoto-
meter unit with associated electronics. The analysis time
from sampling to measurement of the final optical density
is 13.4 minutes. The reaction time is variable between 36
seconds and 12.6 minutes according to the position of the
reagent dispensers within the incubator unit, and the optical
density may be read at the wavelength of any one of eight
mercury lines, between 334 and 623 nm. The same sample
can be dispensed into a pair of process tubes, and up to four
different reagents added to each tube. In this manner blank
measurements can be determined when required. The oper-
ator selects the tests to be performed on each specimen by
means of a keyboard next to the sample tray. Commonly-
requested groups of analyses (biochemical profiles) can be
selected by means of a single key, and some examples of
profiling rates are shown in Table 1. It is possible to intro-
duce any urgent investigation into the middle of the batch
of other analyses, or to perform only a few necessary tests
on a small sample of serum, while performing a wider profile
on the remainder of the batch. Emergency samples are placed
in the next available space in the sample tray, the operator
identifies the sample as an emergency, and keys in the test
required: the instrument then positions the emergency
samples under the sampling unit, samples sufficient serum
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